Vcsa1 Acts as a Marker of Erectile Function Recovery After Gene Therapeutic and Pharmacological Interventions

Journal of Urology

Volumn 181, Issue 6, 2009, Pages 2806-2815

  Calenda, Giulia ^a   Tong, Yuehong ^a   Tar, Moses ^a   Lowe, Daniel ^a   Siragusa, Joseph ^a   Melman, Arnold ^a   Davies, Kelvin P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

gene expression; microarray analysis; muscle; penis; smooth; tadalafil

Indexed keywords

PLASMID VECTOR; PLASMID VECTOR SMAA HSLO; PLASMID VECTOR VAX HSLO; TADALAFIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; GENE; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; GENETIC MARKER; GENETIC TRANSCRIPTION; HSLO GENE; MALE; MICROARRAY ANALYSIS; NONHUMAN; PENIS ERECTION; PLASMID; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VCSA1 GENE;

ANIMALS; CARBOLINES; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENE THERAPY; MALE; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; SALIVARY PROTEINS AND PEPTIDES;

EID: 67349182230     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.01.096     Document Type: Article

References (19)

1. Andersson K.E. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 170 (2003) S6
2. Lin C.S., Ho H.C., Gholami S., Chen K.C., Jad A., and Lue T.F. Gene expression profiling of an arteriogenic impotence model. Biochem Biophys Res Commun 285 (2001) 565
3. User H.M., Zelner D.J., McKenna K.E., and McVary K.T. Microarray analysis and description of SMR1 gene in rat penis in a post-radical prostatectomy model of erectile dysfunction. J Urol 170 (2003) 298
4. Hipp J.D., Davies K.P., Tar M., Valcic M., Knoll A., Melman A., et al. Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases. BJU Int 99 (2007) 418
5. Jung H.G., Shin J.H., Kim K.W., Yu J.Y., Kang K.K., Ahn B.O., et al. Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor. Life Sci 80 (2007) 699
6. Sullivan C.J., Teal T.H., Luttrell I.P., Tran K.B., Peters M.A., and Wessells H. Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats. Physiol Genom 23 (2005) 192
7. Andrade E., Andrade P.M., Borra R.C., Claro J., and Srougi M. cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil. BJU Int 101 (2008) 508
8. Melman A., and Feder M. Gene therapy for the treatment of erectile dysfunction. Nat Clin Pract Urol 5 (2008) 60
9. Melman A., Biggs G., Davies K., Zhao W., Tar M.T., and Christ G.J. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat. Gene Ther 15 (2008) 364
10. Melman A., Bar-Chama N., McCullough A., Davies K., and Christ G. The first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary results. Eur Urol 48 (2005) 314
11. Christ G.J., Rehman J., Day N., Salkoff L., Valcic M., Melman A., et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 275 (1998) H600
12. Tong Y., Tar M., Davelman F., Christ G., Melman A., and Davies K.P. Variable coding sequence protein A1 as a marker for erectile dysfunction. BJU Int 98 (2006) 396
13. Tong Y., Tar M., Melman A., and Davies K. The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU Int 102 (2008) 736
14. Jackson W.F., Huebner J.M., and Rusch N.J. Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles. Microcirculation 3 (1996) 313
15. Tong Y., Tiplitsky S.I., Tar M., Melman A., and Davies K.P. Transcription of G-protein coupled receptors in corporeal smooth muscle is regulated by the endogenous neutral endopeptidase inhibitor sialorphin. J Urol 180 (2008) 760
16. Christ G.J., Day N.S., Day M., Santizo C., Zhao W., Sclafani T., et al. Bladder injection of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1699
17. Melman A., Zhao W., Davies K.P., Bakal R., and Christ G.J. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 170 (2003) 285
18. Tang D.D. Intermediate filaments in smooth muscle. Am J Physiol Cell Physiol 294 (2008) C869
19. Tong Y., Tar M., Monrose V., DiSanto M., Melman A., and Davies K.P. hSMR3A as a marker for patients with erectile dysfunction. J Urol 178 (2007) 338